Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Proceedings of the National Academy of Sciences of the United States of America|September 24, 2002
Myristoylation as a target for inhibiting HIV assembly: unsaturated fatty acids block viral buddingO Wolf Lindwasser, Marilyn D ReshJournal of Virology|May 14, 2004
Human immunodeficiency virus type 1 Gag contains a dileucine-like motif that regulates association with multivesicular bodiesO Wolf Lindwasser, Marilyn D ReshCurrent Molecular Medicine|March 10, 2007
Mechanisms of CD4 downregulation by the Nef and Vpu proteins of primate immunodeficiency virusesO Wolf Lindwasser, Rittik Chaudhuri, Juan S BonifacinoJournal of Virology|February 3, 2007
Downregulation of CD4 by human immunodeficiency virus type 1 Nef is dependent on clathrin and involves direct interaction of Nef with the AP2 clathrin adaptorRittik Chaudhuri, O Wolf Lindwasser, William J Smith, et al.Journal of Virology|January 9, 2009
A basic patch on alpha-adaptin is required for binding of human immunodeficiency virus type 1 Nef and cooperative assembly of a CD4-Nef-AP-2 complexRittik Chaudhuri, Rafael Mattera, O Wolf Lindwasser, et al.Journal of Virology|November 23, 2007
A diacidic motif in human immunodeficiency virus type 1 Nef is a novel determinant of binding to AP-2O Wolf Lindwasser, William J Smith, Rittik Chaudhuri, et al.Journal of Virology|June 6, 2008
Competition model for upregulation of the major histocompatibility complex class II-associated invariant chain by human immunodeficiency virus type 1 NefRichard S Mitchell, Rittik Chaudhuri, O Wolf Lindwasser, et al.Cancer Immunology, Immunotherapy : CII|April 17, 2003
Doxorubicin induces specific immune functions and cytokine expression in peritoneal cellsPeter Ujhazy, Gintaras Zaleskis, Enrico Mihich, et al.Science (New York, N.Y.)|August 12, 2006
Imaging intracellular fluorescent proteins at nanometer resolutionEric Betzig, George H Patterson, Rachid Sougrat, et al.Journal of the National Cancer Institute|February 18, 2026
Approaches to optimize the benefits of immunotherapy and immunotherapy combinations across endometrial cancer typesBradley R Corr, Kara D Romano, Michael D Toboni, et al.Pageof 2